← Open Payments lookup

LOISE WAMEITHI: Open Payments

NPI 1134810344 · LENEXA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,388 in 77 payments from 14 companies in 2025. Trend: 2023 $20 · 2024 $313 · 2025 $1,388

Food & beverage: $1,388
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.16$220
Axsome Therapeutics, Inc.15$215
Neurocrine BioSciences, Inc.3$183
Otsuka America Pharmaceutical, Inc.11$164
Lundbeck LLC5$113
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$91
Teva Pharmaceuticals USA, Inc.4$67
Supernus Pharmaceuticals, Inc.4$67
Tris Pharma Inc4$63
ABBVIE INC.3$60

Products named: REXULTI, HETLIOZ, Auvelity, INGREZZA, CAPLYTA, AUSTEDO XR, Qelbree, Dyanavel XR.

Industry payments across KS — which companies pay providers there.